Ir al contenido principal
Volver a Discusiones

Andrew Huberman: Péptidos, tecnología del sueño y el fin de la obesidad

Healthcare
United States
Iniciada March 14, 2026

Daisy Wolf speaks with Dr. Andrew Huberman, professor of neurobiology and ophthalmology at Stanford University and host of the Huberman Lab podcast. They discuss how the pandemic sparked a consumer health revolution, the emerging peptide and GLP landscape, what the science actually says about focus drugs, and the neurotechnologies Huberman believes will let us write to our own biology within the next five years

Artículos de Fuentes

Añadir afirmación Análisis 0/5
Need to find a specific claim? Search all statements.
🗳️ Join the conversation
5 afirmaciones para votar • Your perspective shapes the analysis
📊 Progress to Consensus Analysis Need: 7+ participants, 20+ votes, 3+ votes per statement
Participants 0/7
Statements (7+ recommended) 5/7
Total Votes 0/20
💡 Progress updates live here. Final readiness is confirmed when all three requirements are met.

Your votes count

No account needed — your votes are saved and included in the consensus analysis. Create an account to track your voting history and add statements.

CLAIM Publicado por will • Mar 14, 2026
Si bien los fármacos de enfoque pueden mejorar la productividad, sus efectos a largo plazo en la salud mental y las normas sociales deben examinarse críticamente.
Traducido por IA · Ver original

While focus drugs may enhance productivity, their long-term effects on mental health and societal norms should be critically examined.

Vote options for this statement: agree, disagree, or unsure
💬 Ver discusión
Be first to respond
Vote to see results
CLAIM Publicado por will • Mar 14, 2026
El entusiasmo por la tecnología del sueño y los neuromejoramientos puede eclipsar la importancia de los cambios fundamentales en el estilo de vida para lograr la salud.
Traducido por IA · Ver original

The enthusiasm for sleep tech and neuroenhancements may overshadow the importance of fundamental lifestyle changes in achieving health.

Vote options for this statement: agree, disagree, or unsure
💬 Ver discusión
Be first to respond
Vote to see results
CLAIM Publicado por will • Mar 14, 2026
El auge de las terapias de péptidos representa un avance revolucionario en la medicina personalizada que podría revolucionar el tratamiento de la obesidad.
Traducido por IA · Ver original

The rise of peptide therapies represents a groundbreaking advancement in personalized medicine that could revolutionize obesity treatment.

Vote options for this statement: agree, disagree, or unsure
💬 Ver discusión
Be first to respond
Vote to see results
CLAIM Publicado por will • Mar 14, 2026
Depender de la neurotecnología para alterar nuestra biología corre el riesgo de simplificar excesivamente los problemas de salud complejos y podría llevar a consecuencias imprevistas.
Traducido por IA · Ver original

Relying on neurotechnology to alter our biology risks oversimplifying complex health issues and could lead to unforeseen consequences.

Vote options for this statement: agree, disagree, or unsure
💬 Ver discusión
Be first to respond
Vote to see results
CLAIM Publicado por will • Mar 14, 2026
La revolución de la salud del consumidor desencadenada por la pandemia empodera a los individuos para tomar control de su bienestar a través de tecnologías y tratamientos innovadores.
Traducido por IA · Ver original

The consumer health revolution sparked by the pandemic empowers individuals to take charge of their wellness through innovative technologies and treatments.

Vote options for this statement: agree, disagree, or unsure
💬 Ver discusión
Be first to respond
Vote to see results

💡 How This Works

  • • Add Statements: Post claims or questions (10-500 characters)
  • • Vote: Agree, Disagree, or Unsure on each statement
  • • Respond: Add detailed pro/con responses with evidence
  • • Consensus: After enough participation, analysis reveals opinion groups and areas of agreement

Society Speaks is open and independent. Your support keeps civic discussion free from advertising and commercial influence.

Support us